Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
about
Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammationRisk of non-Hodgkin lymphoma in association with germline variation in complement genesCancer therapy in the necroptosis eraThe mechanism of necroptosis in normal and cancer cellsStructure of Sad1-UNC84 Homology (SUN) Domain Defines Features of Molecular Bridge in Nuclear EnvelopeProtein glycosylation in cancers and its potential therapeutic applications in neuroblastomaGenome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLLCommon gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma riskCommon infection-related conditions and risk of lymphoid malignancies in older individuals.Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.Genetic susceptibility variants for chronic lymphocytic leukemia.GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaGenome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.Birth order and risk of non-hodgkin lymphoma--true association or bias?Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling.Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte developmentDesign and validity of a clinic-based case-control study on the molecular epidemiology of lymphomaHost genetics in follicular lymphomaFour genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.Apoptosis, autophagy, necroptosis, and cancer metastasisRisk Factors of Non-Hodgkin LymphomaLoss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infectionB3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival.In vivo accumulation of T cells in response to IL-2/anti-IL-2 mAb complexes is dependent in part on the TNF family ligand 4-1BBL.Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies.A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyPRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studiesGermline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.Necroptosis: an alternative cell death program defending against cancer.TRAF molecules in cell signaling and in human diseases
P2860
Q24338129-0C45E245-5CE1-40CD-B0B0-898AF65C7D0BQ24648778-C925B95D-ED48-4181-B859-8E8B44880035Q26766339-723BD6FB-DA13-41EE-BB1B-390B51AABBD2Q27005878-32156823-2893-4832-BCFC-D4C54EC0F40EQ27676189-17DF9583-C7DD-4292-829F-7EBD6FB53289Q28069952-A5192985-74F4-4F69-B0D9-D3BB6A7145B1Q28943377-986D123C-07A6-4B70-890E-F2A68FC74EADQ33434511-750BF5A7-6106-4155-BBF3-12C1A7239CE6Q33682902-625FDEBE-638A-4E6D-A4F3-0AD41976D141Q33741481-E79926AF-FC6F-4C43-ABA0-2C33B23D5F2AQ33780771-A8853393-E6B1-4A88-A161-5051A05EB339Q33886166-323E6E54-C602-4D5D-BF66-C995C2E019D5Q34033939-184E604B-B4A4-4E06-BE43-807153852F77Q34179580-0F83A8FD-66A8-427A-B8CF-CA8C9506169CQ34292891-C2D608C7-38F1-4531-9BCB-876998E63E20Q34340672-49D525AB-EA32-4BC7-841A-B7BD282D48CDQ34441264-72600151-E07A-4D0A-9893-64152F068D10Q34800968-E39E8218-7271-4B29-BE14-F9D42DE9BC8BQ35009957-717F2A84-2B2D-4338-BE86-3E04002F6DE2Q35031964-76543A95-FF4E-4588-B5D2-A1F6C826C26DQ35038312-35EFBFF3-1B7D-4044-872B-09B0C4D8D8D7Q35070335-0D195A5B-CFAD-4E6E-9878-9B54E98460CFQ35112029-8246788A-41BC-4DD8-9602-5B92F07D5620Q35128650-F07435F2-8B00-4AE9-A9FE-205C39180E0CQ35499320-675F819F-824D-4C89-8B25-CF8A7BD24190Q35679587-CBC6F6EF-78C2-4B0A-AE8D-6FC828128591Q35879359-14C94154-CD45-4005-B6AF-085D5FA76A8EQ36120539-107DE312-3413-4A66-A029-4FEBDD9F1482Q36137122-6082FC54-E262-4F08-8642-8D47B979D598Q36153051-C14B15E3-3477-4D4C-BD7D-202F6B4AE9ECQ36182352-53A2823C-1EC2-419E-BF23-0415F6C4F52AQ36306403-E0822206-5E2A-45B5-AA1B-92324E3A0C9FQ36354265-D29F8CF2-1DE6-4BA8-9AAC-CE15F91F5C37Q36440086-F1AA664F-ED4E-411A-8A5A-301E2A834236Q36551642-589774E5-CC71-49D3-BC0A-A8EC76D206B3Q36650573-AF851827-C93B-48A3-8818-4D6764EA65A1Q36660850-96192DCB-5D79-4138-9709-80A485F2305AQ36680976-8C103931-A9FE-4B0C-874B-79E01AE6A65DQ36880241-E59ECE14-E652-49A7-8873-159A07A2E412Q36972287-B3DF5F2F-1C4F-4E6A-893C-FF6FA62AFA2A
P2860
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
@ast
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
@en
type
label
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
@ast
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
@en
prefLabel
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
@ast
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
@en
P2093
P2860
P1433
P1476
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
@en
P2093
Ahmet Dogan
Alice H Wang
Diane Jelinek
James R Cerhan
Mark Liebow
Neil E Kay
Stephen M Ansell
Susan L Slager
Thomas E Witzig
Thomas M Habermann
P2860
P304
P356
10.1182/BLOOD-2007-05-088682
P407
P577
2007-09-07T00:00:00Z